Presentation: Serum interleukin-6 is a biomarker of survival in women with advanced stage and optimally resected epithelial ovarian cancer (2015 Annual Meeting on Women's Cancer®)

Working to Eradicate Gynecologic Cancers

443
Serum interleukin-6 is a biomarker of survival in women with advanced stage and optimally resected epithelial ovarian cancer

Sunday, March 29, 2015: 7:00 AM

Salon C-D (Hilton Chicago)

S. A. Martin, B. Y. Karlan, C. Walsh, I. Cass, B. J. Rimel and A. J. Li
Cedars-Sinai Medical Center, Los Angeles, CA